anticache

Research news: Pinpoint targeting instead of shotgun approach

18.12.2015


Integrins help cells communicate with and adapt to their environment. Also cancer cells depend on their properties to survive and spread throughout the body. Now TUM-IAS Carl von Linde Senior Fellow Horst Kessler, doctoral candidate Tobias Kapp and his colleague Dr. Oleg Maltsev have successfully developed a small, highly active molecule that binds to a specific integrin that operates in many types of cancer. In the future it may allow patient-specific diagnoses and subsequent targeted treatment of tumor cells.

A full press release can be found here.